Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-01-06 @ 7:48 PM
Study NCT ID:
NCT01872260
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-29
First Post:
2013-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-22
Start Date Type:
ACTUAL
Primary Completion Date:
2027-02-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-26
Completion Date Type:
ESTIMATED
First Submit Date:
2013-05-30
First Submit QC Date:
None
Study First Post Date:
2013-06-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-27
Last Update Post Date:
2025-10-29
Last Update Post Date Type:
ESTIMATED